The FY24 PCRP Data Science Award mechanism supports research where quantitative and analytical approaches, processes, and/or systems are developed and/or used to obtain knowledge and insight from large and/or complex sets of prostate cancer data. If successful, the studies will enable progress toward addressing one or more of the FY24 PCRP Overarching Challenges. It is expected that any resources, tools, or computational processes generated by this award will be openly shared with the prostate cancer research and patient community. This mechanism is intended to fund research built upon the logic, concepts, and methods of one or more of the following research areas as they pertain to prostate cancer:
• Computational biology
• Bioinformatics
• Artificial intelligence and machine learning
• Epidemiology
• Analysis of –omics data
• Medical imaging
• Digital pathology
• Analysis of other clinically annotated datasets
Applications may combine diverse data types for integrative analysis to increase knowledge about prostate cancer with respect to the FY24 PCRP Overarching Challenges. Applications that propose to develop resources or tools that allow research, clinical care, and patient community access to standardized and harmonized datasets for real-time clinical care applications are of particular interest; however, this award must not be used to support the development of new datasets. Studies utilizing data derived from large patient studies that include long-term health records or repositories with well-annotated and high-quality biospecimens are encouraged.
Deadlines:
• Required Pre-Application Deadline: Aug. 9, 2024
• Application Submission Deadline: Aug. 30, 2024
The mission of the FY24 PCRP is to fund research that will eliminate death and suffering from prostate cancer and enhance the well-being of Service Members and their Families, Veterans, and all the patients and caregivers who are experiencing the impact of the disease. Within this context, the PCRP is interested in supporting research that addresses specific gaps in prostate cancer research and clinical care; therefore, applications are required to address one or more of the following FY24 PCRP Overarching Challenges:
• Improve quality of life to enhance outcomes and overall health and wellness for those impacted by prostate cancer
• Develop new treatments or improve upon existing therapies to improve outcomes for men with lethal prostate cancer
• Advance health equity and reduce disparities in prostate cancer
• Define the biology of prostate cancer progression to lethal prostate cancer to reduce death
Each investigator may be named on only one FY24 PCRP Data Science Award application as a PI, Initiating PI, or Partnering PI.
Independent investigators at all levels are eligible to be named as a PI, Initiating PI, or Partnering PI on an application for the FY24 PCRP Data Science Award.
An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by or affiliated with an eligible organization.
The anticipated direct costs budgeted for the entire period of performance for an FY24 PCRP Data Science Award should not exceed $1.0M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.